Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals.
暂无分享,去创建一个
C. Smith | L. Herzenberg | K. Okumura | H. Yagita | P. Katsikis | M. Alderson | N. Kayagaki | E. Wunderlich | M. García-Ojeda | E. S. Wunderlich
[1] E. Lacy,et al. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. , 1996, Journal of immunology.
[2] T. Idziorek,et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons , 1995, The Journal of experimental medicine.
[3] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[4] G. Mills,et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. , 1995, International immunology.
[5] P. Krammer,et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.
[6] C. Smith,et al. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals , 1995, The Journal of experimental medicine.
[7] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[8] S. Ju,et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.
[9] Seamus J. Martin,et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.
[10] P. Krammer,et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.
[11] T. Curiel,et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.
[12] S. Nagata,et al. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody , 1995, The Journal of experimental medicine.
[13] J. Gribben,et al. CTLA4 mediates antigen-specific apoptosis of human T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Smith,et al. Fas ligand mediates activation-induced cell death in human T lymphocytes , 1995, The Journal of experimental medicine.
[15] D. Kraft,et al. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. , 1995, Immunity.
[16] R. Coffman,et al. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] F. Ramsdell,et al. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. , 1994, International immunology.
[18] F. Barré-Sinoussi,et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Tschopp,et al. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.
[20] H Hengartner,et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.
[21] Z. Darżynkiewicz,et al. CD4 engagement induces Fas antigen‐dependent apoptosis of T cells in vivo , 1994, European journal of immunology.
[22] N. Boiani,et al. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines , 1994 .
[23] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[24] D. Williams,et al. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. , 1994, Blood.
[25] Takashi Suda,et al. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.
[26] J. Berzofsky,et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. , 1993, Science.
[27] N. Chirmule,et al. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. , 1993, Blood.
[28] F. Ramsdell,et al. Fas transduces activation signals in normal human T lymphocytes , 1993, The Journal of experimental medicine.
[29] H. Schuitemaker,et al. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. , 1993, The Journal of infectious diseases.
[30] N. Copeland,et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF , 1993, Cell.
[31] J. Heeney,et al. Programmed cell death in AIDS-related HIV and SIV infections. , 1993, AIDS research and human retroviruses.
[32] N. Haigwood,et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.
[33] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[34] A. Capron,et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.
[35] J. Ameisen. Activation-induced Death by Apoptosis in CD4 + T Cells from Human Immunodeficiency Virus-lnfected Asymptomatic Individuals By Her% Groux,* G6rard Torpier,* Didier Mont6,* Yves Mouton,~ , 1992 .
[36] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[37] P. Möller,et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.
[38] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.